جهت دسترسی به کاربرگه ی زیر، از این لینک استفاده کنید. http://78.39.227.9/handle/Hannan/47276
Title: EMerging BiomARKers in Inflammatory Bowel Disease (EMBARK) study identifies fecal calprotectin, serum MMP9, and serum IL-22 as a novel combination of biomarkers for Crohn's disease activity: role of cross-sectional imaging.
Authors: Faubion, William a;Fletcher, Joel G;O'Byrne, Sharon;Feagan, Brian G;de Villiers, Willem Js;Salzberg, Bruce;Plevy, Scott;Proctor, Deborah D;Valentine, John F;Higgins, Peter D;Harris, Jeffrey M;Diehl, Lauri;Wright, Lilyan;Tew, Gaik Wei;Luca, Diana;Basu, Karen;Keir, Mary E
Keywords: Adolescent;Adult;Aged;Biological Markers;Biological Markers: metabolism;Colonoscopy;Crohn Disease;Crohn Disease: metabolism;Crohn Disease: radiography;Feces;Feces: chemistry;Female;Humans;Interleukins;Interleukins: blood;Leukocyte L1 Antige
Issue Date: 2013
Abstract: OBJECTIVES: In Crohn's disease (CD), clinical symptoms correspond poorly to inflammatory disease activity. Biomarkers reflective of mucosal and bowel wall inflammation would be useful to monitor disease activity. The EMBARK study evaluated disease activit
URI: http://www.ncbi.nlm.nih.gov/pubmed/24126633
http://ebook.muk.ac.ir/handle/Hannan/47276
ISSN: 1572-0241 (Electronic)\r0002-9270 (Linking)
Format: VOLUME : 108
ISSUE : 12
START PAGE : 1891
END PAGES : 900
Appears in Collections:2013

Files in This Item:
File Description SizeFormat 
medicine article d (4).pdf230.96 kBAdobe PDFThumbnail
Download    Request a copy


تمامی کاربرگه ها در کتابخانه ی دیجیتال حنان به صورت کامل محافظت می شوند.